The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors
Open accessAbstract
Hepatocellular carcinoma (HCC) is the fourth cause of cancer related mortality, and its incidence is rapidly increasing. Viral hepatitis, alcohol abuse, and exposure to hepatotoxins are major risk factors, but nonalcoholic fatty liver disease (NAFLD) associated with obesity, insulin resistance, and type 2 diabetes, is an increasingly recognized trigger, especially in developed countries. Older age, severity of insulin resistance and diabetes, and iron overload have been reported to predispose to HCC in this context. Remarkably, HCCs have been reported in non-cirrhotic livers in a higher proportion of cases in NAFLD patients than in other etiologies. Inherited factors have also been implicated to explain the different individual susceptibility to develop HCC, and their role seems magnified in fatty liver, where only a minority of affected subjects progresses to cancer. In particular, the common I148M variant of the PNPLA3 gene influencing hepatic lipid metabolism influences HCC risk independently of its effect on the progression of liver fibrosis. Recently, rare loss-of-function mutations in Apolipoprotein B resulting in very low density lipoproteins hepatic retention and in Telomerase reverse transcriptase influencing cellular senescence have also been linked to HCC in NAFLD. Indeed, hepatic stellate cells senescence has been suggested to bridge tissue aging with alterations of the intestinal microbiota in the pathogenesis of obesity-related HCC. A deeper understanding of the mechanisms mediating hepatic carcinogenesis during insulin resistance, and the identification of its genetic determinants will hopefully provide new diagnostic and therapeutic tools.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Table 8. Factors associated with a higher risk of HCC occurrence in MASLD.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [532]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,710
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Rising Incidence of Hepatocellular Carcinoma in the United States
El‐Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,865
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,687
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli‐Labate, A. M., Bianchi, G. P., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,570
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., CARUCCI, P., Musso, A., Paolis, P. D., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,436
Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368
The burden of liver disease in Europe: A review of available epidemiological data
Blachier, M., Leleu, H., Peck‐Radosavljevic, M., Valla, D. C., & Roudot‐Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,340
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El‐Serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,242
Senescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124
Michelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974
Mechanisms of hepatic fibrogenesis
Lee, U. E., & Friedman, S. L. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.005 · Cited by 923
Sookoian, S. C., & Pirola, C. J. (2011) · Hepatology · doi:10.1002/hep.24283 · Cited by 917
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 872
Non‐alcoholic fatty liver disease
Angulo, P., & Lindor, K. D. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s1.10.x · Cited by 838
Lazo, M., Hernáez, R., Eberhardt, M. S., Bonekamp, S., Kamel, I. R., Güallar, E., Koteish, A. A., Brancati, F. L., & Clark, J. M. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws448 · Cited by 804
Davila, J. A., Morgan, R. O., Shaib, Y. H., McGlynn, K. A., & El‐Serag, H. B. (2005) · Gut · doi:10.1136/gut.2004.052167 · Cited by 706
Marrero, J., Fontana, R. J., Su, G. L., Conjeevaram, H. S., Emick, D. M., & Lok, A. S.-F. (2002) · Hepatology · doi:10.1053/jhep.2002.36939 · Cited by 659
Valenti, L., Al‐Serri, A., Daly, A. K., Galmozzi, E., Rametta, R., Dongiovanni, P., Nobili, V., Mozzi, E., Roviaro, G., Vanni, E., et al. (2010) · Hepatology · doi:10.1002/hep.23622 · Cited by 651
Self-citationThe natural history of compensated cirrhosis due to hepatitis C virus
Sangiovanni, A., Prati, G. M., Fasani, P., Ronchi, G., Romeo, R., Manini, M. A., Ninno, E. D., Morabito, A., & Colombo, M. (2006) · Hepatology · doi:10.1002/hep.21176 · Cited by 626
He, S., McPhaul, C., Li, J. Z., Garuti, R., Kinch, L. N., Grishin, N. V., Cohen, J. C., & Hobbs, H. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064501 · Cited by 618
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
Dyson, J., Jaques, B., Chattopadyhay, D., Lochan, R., Graham, J., Das, D., Aslam, T., Patanwala, I., Gaggar, S., Cole, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.011 · Cited by 603
Paradis, V., Zalinski, S., Chelbi, E., Guedj, N., Degos, F., Vilgrain, V., Bédossa, P., & Belghiti, J. (2008) · Hepatology · doi:10.1002/hep.22734 · Cited by 598
Liu, Y.-L., Patman, G. L., Leathart, J. B. S., Piguet, A.-C., Burt, A. D., Dufour, J.-F., Day, C. P., Daly, A. K., Reeves, H. L., & Anstee, Q. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.02.030 · Cited by 549
Chen, C., Yang, H., Yang, W., Liu, C., Chen, P., You, S., Wang, L., Sun, C., Lu, S., Chen, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.073 · Cited by 548
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma
Marrero, J. A., Fontana, R. J., Fu, S., Conjeevaram, H. S., Su, G. L., & Lok, A. S.-F. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.005 · Cited by 515
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies
Larsson, S. C., & Wolk, A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603932 · Cited by 501
Insulin resistance–associated hepatic iron overload
Mendler, M.-H., Turlin, B., Moirand, R., Jouanolle, A., Sapey, T., Guyader, D., Gall, J. L., Brissot, P., David, V., & Deugnier, Y. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70401-4 · Cited by 494
Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver
Teli, M. R., Day, C., James, O., Burt, A. D., & Bennett, M. K. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91685-7 · Cited by 484
Adipokines in liver diseases #
Marra, F., & Bertolani, C. (2009) · Hepatology · doi:10.1002/hep.23046 · Cited by 468
Yuan, X., Waterworth, D. M., Perry, J. R. B., Lim, N., Song, K. S., Chambers, J. C., Zhang, W., Vollenweider, P., Stirnadel-Farrant, H. A., Johnson, T., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.012 · Cited by 457
Variant in PNPLA3 is associated with alcoholic liver disease
Tian, C., Stokowski, R. P., Kershenobich, D., Ballinger, D. G., & Hinds, D. A. (2009) · Nature Genetics · doi:10.1038/ng.488 · Cited by 435
Bugianesi, E., Manzini, P. M., D’Antico, S., Vanni, E., Longo, F., Leone, N., Massarenti, P., Piga, A. G., Marchesini, G., & Rizzetto, M. (2004) · Hepatology · doi:10.1002/hep.20023 · Cited by 434
Inhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery
Rudolph, K. L., Chang, S., Millard, M., Schreiber-Agus, N., & DePinho, R. A. (2000) · Science · doi:10.1126/science.287.5456.1253 · Cited by 424
Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
Yasui, K., Hashimoto, E., Komorizono, Y., Koike, K., Arii, S., Imai, Y., Shima, T., Kanbara, Y., Saibara, T., Mori, T., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.01.023 · Cited by 420
Nair, S. P., Verma, S., & Thuluvath, P. J. (2002) · Hepatology · doi:10.1053/jhep.2002.30318 · Cited by 419
Metabolic syndrome and hepatocellular carcinoma: Two growing epidemics with a potential link
Siegel, A. B., & Zhu, A. X. (2009) · Cancer · doi:10.1002/cncr.24687 · Cited by 399
Day, C. P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.017 · Cited by 398
Llovet, J. M., Chen, Y., Wurmbach, E., Roayaie, S., Fiel, M. I., Schwartz, M., Thung, S. N., Khitrov, G., Zhang, W., Villanueva, A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.014 · Cited by 388
A feed-forward loop amplifies nutritional regulation of PNPLA3
Huang, Y., He, S., Li, J. Z., Seo, Y.-K., Osborne, T. F., Cohen, J. C., & Hobbs, H. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003585107 · Cited by 386
Kumar, V., Kato, N., Urabe, Y., Takahashi, A., Muroyama, R., Hosono, N., Otsuka, M., Tateishi, R., Omata, M., Nakagawa, H., et al. (2011) · Nature Genetics · doi:10.1038/ng.809 · Cited by 384
Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target
Dongiovanni, P., Fracanzani, A. L., Fargion, S. R., & Valenti, L. V. C. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.008 · Cited by 364
Self-citationHepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Shimada, M., Hashimoto, E., Taniai, M., Hasegawa, K., Okuda, H., Hayashi, N., Takasaki, K., & Ludwig, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00099-5 · Cited by 356
Minireview: IGF, Insulin, and Cancer
Gallagher, E. J., & LeRoith, D. (2011) · Endocrinology · doi:10.1210/en.2011-0231 · Cited by 356
Zhang, H., Zhai, Y., Hu, Z., Wu, C. H., Qian, J., Jia, W., Ma, F., Huang, W., Yu, L., Yue, W., et al. (2010) · Nature Genetics · doi:10.1038/ng.638 · Cited by 351
Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Welzel, T. M., Graubard, B. I., Quraishi, S. M., Zeuzem, S., Davila, J. A., El‐Serag, H. B., & McGlynn, K. A. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.160 · Cited by 326
Lai, S., Chen, P., Liao, K.-F., Muo, C., Lin, C., & Sung, F.-C. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.384 · Cited by 311
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
Hassan, M. M., Curley, S. A., Li, D., Kaseb, A. O., Davila, M. L., Abdalla, E. K., Javle, M. M., Moghazy, D. M., Lozano, R. D., Abbruzzese, J. L., et al. (2010) · Cancer · doi:10.1002/cncr.24982 · Cited by 308
Pirazzi, C., Adiels, M., Burza, M. A., Mancina, R. M., Levin, M. C., Ståhlman, M., Taskinen, M., Orho‐Melander, M., Perman, J., Pujia, A., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.030 · Cited by 304
Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians
Stickel, F., Buch, S., Lau, K., zu Schwabedissen, H. E. M., Berg, T., Ridinger, M., Rietschel, M., Schafmayer, C., Braun, F., Hinrichsen, H. M., et al. (2010) · Hepatology · doi:10.1002/hep.24017 · Cited by 291
Valenti, L. V. C., Fracanzani, A. L., Dongiovanni, P., Bugianesi, E., Marchesini, G., Manzini, P. M., Vanni, E., & Fargion, S. R. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01192.x · Cited by 289
Self-citationValenti, L. V. C., Fracanzani, A. L., Bugianesi, E., Dongiovanni, P., Galmozzi, E., Vanni, E., Canavesi, E., Lattuada, E., Roviaro, G., Marchesini, G., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.11.013 · Cited by 280
Self-citationThe role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans
El‐Serag, H. B., Richardson, P., & Everhart, J. E. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04054.x · Cited by 273
Regulation of the human catalytic subunit of telomerase (hTERT)
Daniel, M. G., Peek, G. W., & Tollefsbol, T. O. (2012) · Gene · doi:10.1016/j.gene.2012.01.095 · Cited by 272
Valenti, L. V. C., Rumi, M. G., Galmozzi, E., Aghemo, A., Menico, B. D., Nicola, S. D., Dongiovanni, P., Maggioni, M., Fracanzani, A. L., Rametta, R., et al. (2010) · Hepatology · doi:10.1002/hep.24123 · Cited by 261
Self-citationA Spectrum of Severe Familial Liver Disorders Associate with Telomerase Mutations
Calado, R. T., Regal, J. A., Kleiner, D. E., Schrump, D. S., Peterson, N. R., Pons, V., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007926 · Cited by 258
Dongiovanni, P., Anstee, Q. M., & Valenti, L. V. C. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990381 · Cited by 239
Self-citationFargion, S., Mattioli, M., Fracanzani, A. L., Sampietro, M., Tavazzi, D., Fociani, P., Taioli, E., Valenti, L. V. C., & Fiorelli, G. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04052.x · Cited by 236
Steatohepatitic Hepatocellular Carcinoma (SH-HCC)
Salomao, M. A., Yu, W. M., Brown, R. S., Emond, J. C., & Lefkowitch, J. H. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181f31caa · Cited by 233
Trépo, E., Nahon, P., Bontempi, G., Valenti, L. V. C., Falleti, E., Nischalke, H. D., Hamza, S., Corradini, S. G., Burza, M. A., Guyot, E., et al. (2013) · Hepatology · doi:10.1002/hep.26767 · Cited by 233
Trichopoulos, D., Bamia, C., Λάγιου, Π., Fedirko, V., Trépo, E., Jenab, M., Pischon, T., Nöthlings, U., Overved, K., Tjønneland, A. M., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr395 · Cited by 233
Obesity and diabetes as a risk factor for hepatocellular carcinoma
Regimbeau, J. M., Colombat, M., Mognol, P., Durand, F., Abdalla, E. K., Degott, C., Degos, F., Farges, O., & Belghiti, J. (2004) · Liver Transplantation · doi:10.1002/lt.20033 · Cited by 225
Schnabl, B., Purbeck, C. A., Choi, Y. H., Hagedorn, C. H., & Brenner, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50097 · Cited by 224
Constitutional telomerase mutations are genetic risk factors for cirrhosis
Calado, R. T., Brudno, J. N., Chaudhry, P. M., Kovacs, J. J., Wu, C. O., Zago, M. A., Chanock, S. J., BOYER, T. D., & Young, N. S. (2011) · Hepatology · doi:10.1002/hep.24173 · Cited by 195
Pekow, J. R., Bhan, A. K., Zheng, H., & Chung, R. T. (2007) · Cancer · doi:10.1002/cncr.22701 · Cited by 183
Sorrentino, P., D’Angelo, S., Ferbo, U., Micheli, P., Bracigliano, A., & Vecchione, R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.011 · Cited by 182
Trépo, E., Pradat, P., Potthoff, A., Momozawa, Y., Quertinmont, E., Gustot, T., Lemmers, A., Berthillon, P., Amininejad, L., Chevallier, M., et al. (2011) · Hepatology · doi:10.1002/hep.24350 · Cited by 180
Nkontchou, G., Ziol, M., Aout, M., Lhabadie, M., Baazia, Y., Mahmoudi, A., Roulot, D. M., Ganne‐Carrié, N., Grando–Lemaire, V., Trinchet, J., et al. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01441.x · Cited by 179
Yamashita, T., Honda, M., Takatori, H., Nishino, R., Minato, H., Takamura, H., Ohta, T., & Kaneko, S. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.036 · Cited by 178
Miki, D., Ochi, H., Hayes, C. N., Abe, H., Yoshima, T., Aikata, H., Ikeda, K., Kumada, H., Toyota, J., Morizono, T., et al. (2011) · Nature Genetics · doi:10.1038/ng.876 · Cited by 176
Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis
Nahon, P., & Zucman‐Rossi, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.035 · Cited by 174
Stickel, F., & Hellerbrand, C. (2010) · Gut · doi:10.1136/gut.2009.199661 · Cited by 174
Rudnick, D. A., & Perlmutter, D. H. (2005) · Hepatology · doi:10.1002/hep.20815 · Cited by 173
Dietary Iron Overload Induces Visceral Adipose Tissue Insulin Resistance
Dongiovanni, P., Ruscica, M., Rametta, R., Recalcati, S., Steffani, L., Gatti, S., Girelli, D., Cairo, G., Magni, P., Fargion, S. R., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.019 · Cited by 172
Self-citationMetabolic syndrome and hepatocellular carcinoma risk
Turati, F., Talamini, R., Pelucchi, C., Polesel, J., Franceschi, S., Crispo, A., Izzo, F., Vecchia, C. L., Boffetta, P., & Montella, M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.492 · Cited by 159
The Association Between Metabolic Syndrome and Hepatocellular Carcinoma
Jinjuvadia, R., Patel, S., & Liangpunsakul, S. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182a030c4 · Cited by 141
Vinciguerra, M., Carrozzino, F., Peyrou, M., Carlone, S., Montesano, R., Benelli, R., & Foti, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.027 · Cited by 128
Takuma, Y. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i12.1436 · Cited by 127
Guyot, E., Sutton, A., Rufat, P., Laguillier, C., Mansouri, A., Moreau, R., Ganne‐Carrié, N., Beaugrand, M., Charnaux, N., Trinchet, J., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.036 · Cited by 126
Nischalke, H. D., Berger, C., Luda, C., Berg, T., Müller, T., Grünhage, F., Lammert, F., Coenen, M., Krämer, B., Körner, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027087 · Cited by 125
Iron in Nonhemochromatotic Liver Disorders
Alla, V., & Bonkovsky, H. L. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-923317 · Cited by 124
Family history of liver cancer and hepatocellular carcinoma
Turati, F., Edefonti, V. C., Talamini, R., Ferraroni, M., Malvezzi, M., Bravi, F., Franceschi, S., Montella, M., Polesel, J., Zucchetto, A., et al. (2011) · Hepatology · doi:10.1002/hep.24794 · Cited by 122
Houglum, K., Ramm, G. A., Crawford, D. H., Witztum, J. L., Powell, L. W., & Chojkier, M. (1997) · Hepatology · doi:10.1002/hep.510260311 · Cited by 122
Falleti, E., Fabris, C., Cmet, S., Cussigh, A., Bitetto, D., Fontanini, E., Fornasiere, E., Bignulin, S., Fumolo, E., Bignulin, E., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02534.x · Cited by 121
Alexander, J., Torbenson, M. S., Wu, T., & Yeh, M. M. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12116 · Cited by 119
Burza, M. A., Pirazzi, C., Maglio, C., Sjöholm, K., Mancina, R. M., Svensson, P., Jacobson, P., Adiels, M., Baroni, M. G., Borén, J., et al. (2012) · Digestive and Liver Disease · doi:10.1016/j.dld.2012.05.006 · Cited by 119
Transcriptional Regulation of Telomerase Activity
Dwyer, J., He, L., Xu, D., & Liu, J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.022 · Cited by 89
Cefalu, A. B., Pirruccello, J. P., Noto, D., Gabriel, S., Valenti, V., Gupta, N., Spina, R., Tarugi, P., Kathiresan, S., & Averna, M. R. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301101 · Cited by 86
Hassan, M. M., Kaseb, A. O., Etzel, C. J., El‐Serag, H. B., Spitz, M. R., Chang, P., Stemke‐Hale, K., Liu, M., Rashid, A., Shama, M., et al. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22057 · Cited by 85
Trépo, E., Guyot, E., Ganne‐Carrié, N., Degré, D., Gustot, T., Franchimont, D. P., Sutton, A., Nahon, P., & Moreno, C. (2011) · Hepatology · doi:10.1002/hep.25518 · Cited by 78
Viganò, M., Valenti, L. V. C., Lampertico, P., Facchetti, F., Motta, B. M., D’Ambrosio, R., Romagnoli, S., Dongiovanni, P., Donati, B., Fargion, S. R., et al. (2013) · Hepatology · doi:10.1002/hep.26445 · Cited by 77
Self-citationPrimary hepatocellular carcinoma and metabolic syndrome: An update
Rahman, R. N. (2013) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v5.i9.186 · Cited by 76
Tanaka, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i39.5180 · Cited by 76
The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?
Valenti, L. V. C., Fracanzani, A. L., & Fargion, S. R. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0152-9 · Cited by 76
Iron-Dependent Regulation of MDM2 Influences p53 Activity and Hepatic Carcinogenesis
Dongiovanni, P., Fracanzani, A. L., Cairo, G., Megazzini, C., Gatti, S., Rametta, R., Fargion, S. R., & Valenti, L. V. C. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090249 · Cited by 72
Self-citationPNPLA3 I148M variant and hepatocellular carcinoma: A common genetic variant for a rare disease
Valenti, L. V. C., Dongiovanni, P., Corradini, S. G., Burza, M. A., & Romeo, S. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2012.12.006 · Cited by 67
Self-citationHepatocellular carcinoma with nonalcoholic steatohepatitis
Mori, S., Yamasaki, T., Sakaida, I., Takami, T., Sakaguchi, E., Kimura, T., Kurokawa, F., Maeyama, S., & Okita, K. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-003-1308-3 · Cited by 66
Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma
Corradini, S. G., Burza, M. A., Molinaro, A., & Romeo, S. (2011) · Hepatology · doi:10.1002/hep.24244 · Cited by 58
Valenti, L. V. C., Motta, B. M., Soardo, G., Iavarone, M. A., Donati, B., Sangiovanni, A., Carnelutti, A., Dongiovanni, P., Rametta, R., Bertelli, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075982 · Cited by 56
Self-citationValenti, L. V. C. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i22.2813 · Cited by 52
The effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis
Stal, P. I., Hultcrantz, R. W., Möller, L., & Eriksson, L. C. (1995) · Hepatology · doi:10.1002/hep.1840210237 · Cited by 50
Lee, S. S., Jeong, S., Byoun, Y.-S., Chung, S. M., Seong, M. H., Sohn, H. R., Min, B. Y., Jang, E. S., Kim, J., Park, G. J., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-335 · Cited by 49
Mutations in telomerase catalytic protein in Japanese children with aplastic anemia.
Liang, J. B., Yagasaki, H., Kamachi, Y., Hama, A., Matsumoto, K., Kato, K., Kudo, K., & Kojima, S. (2006) · PubMed · Cited by 45
Hemochromatosis in Italy in the Last 30 Years: Role of Genetic and Acquired Factors
Fracanzani, A. L., Piperno, A., Valenti, L. V. C., Fraquelli, M., Coletti, S., Maraschi, A., Consonni, D., Coviello, E., Conte, D., & Fargion, S. R. (2009) · Hepatology · doi:10.1002/hep.23333 · Cited by 45
Bonnefont‐Rousselot, D., Condat, B., Sassolas, A., Chebel, S., Bittar, R., Federspiel, M.-C., Cazals-Hatem, D. L., & Bruckert, É. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282ffd9f8 · Cited by 40
Lonardo, A., Tarugi, P., Ballarini, G., & Bagni, A. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026646618643 · Cited by 40
Iron promotes DEN initiated GST-P foci in rat liver
Carthew, P. (1997) · Carcinogenesis · doi:10.1093/carcin/18.3.599 · Cited by 39
Valenti, L. V. C., Fracanzani, A. L., Rametta, R., Fraquelli, M., Soverini, G., Pelusi, S., Dongiovanni, P., Conte, D., & Fargion, S. R. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.041 · Cited by 37
Self-citationFracanzani, A. L., Fargion, S. R., Stazi, M. A., Valenti, L. V. C., Amoroso, P., Cariani, E., Sangiovanni, A., Tommasini, M., Rossini, A., Bertelli, C., et al. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.03.007 · Cited by 33
Telomerase mutation: A genetic risk factor for cirrhosis
Chaiteerakij, R., & Roberts, L. R. (2011) · Hepatology · doi:10.1002/hep.24304 · Cited by 22
Valenti, L. V. C., Dongiovanni, P., Maggioni, M., Motta, B. M., Rametta, R., Milano, M., Fargion, S. R., Reggiani, P., & Fracanzani, A. L. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.011 · Cited by 19
Self-citationThe effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis*1
Stal, P. I. (1995) · Hepatology · doi:10.1016/0270-9139(95)90115-9 · Cited by 13
Devkota, S., & Turnbaugh, P. J. (2013) · Nature · doi:10.1038/nature12404 · Cited by 6
Research works printed but not linked: 1
- 10.2353/amjpath.2010.090249 · DOI
Cited by
Sorted by citations
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis
Xu, F., Liu, C., Zhou, D., & Zhang, L. (2016) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415627681 · Cited by 773
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
Marengo, A., Rosso, C., & Bugianesi, E. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-090514-013832 · Cited by 757
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 558
Metadata
- Authors
- Dongiovanni, P.
- Affiliations
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Corresponding author
- Dongiovanni, Paola
- ORCID
- Dongiovanni, Paola
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 20
- Issue
- 36
- Pages
- 12945
- ISSN
- 1007-9327 (ISSN-L)
- PMC
- PMC4177475
- OpenAlex
- W2018207417
- Cited by
- 145
- References
- 124
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 11 · 2023: 7 · 2022: 11 · 2021: 13 · 2020: 16 · 2019: 12 · 2018: 19 · 2017: 12 · 2016: 17 · 2015: 16
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Gastroenterology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novo Nordisk Fonden (NNF14OC0009321)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- hepatocellular carcinoma, non-alcoholic fatty liver disease, insulin resistance, PNPLA3 I148M variant, telomerase reverse transcriptase, cellular senescence, gut microbiota, obesity, type 2 diabetes, iron overload, hepatocarcinogenesis, genetic susceptibility, environmental risk factors
- MeSH terms
- Animals, Carcinoma, Hepatocellular, Humans, Liver, Liver Neoplasms, Phenotype, Prognosis, Risk Factors, Disease Progression, Risk Assessment, Genetic Predisposition to Disease, Gene-Environment Interaction, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
